StreetInsider.com News Articles

Nomura/Instinet Upgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Tue, 14 Oct 2025 06:13:50 -0500

Nomura/Instinet analyst Tushar Mohata upgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Reduce to Neutral with a price target of MYR3.00 (from MYR2.90).

Nomura/Instinet Upgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Tue, 14 Oct 2025 06:13:50 -0500

Nomura/Instinet analyst Tushar Mohata upgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Reduce to Neutral with a price target of MYR3.00 (from MYR2.90).

Nomura/Instinet Upgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Tue, 14 Oct 2025 06:13:50 -0500

Nomura/Instinet analyst Tushar Mohata upgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Reduce to Neutral with a price target of MYR3.00 (from MYR2.90).

Nomura/Instinet Upgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Tue, 14 Oct 2025 06:13:50 -0500

Nomura/Instinet analyst Tushar Mohata upgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Reduce to Neutral with a price target of MYR3.00 (from MYR2.90).

Nomura/Instinet Upgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Tue, 14 Oct 2025 06:13:50 -0500

Nomura/Instinet analyst Tushar Mohata upgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Reduce to Neutral with a price target of MYR3.00 (from MYR2.90).

Nomura/Instinet Upgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Tue, 14 Oct 2025 06:13:50 -0500

Nomura/Instinet analyst Tushar Mohata upgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Reduce to Neutral with a price target of MYR3.00 (from MYR2.90).

UBS Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Sun, 08 Jun 2025 23:59:08 -0500

UBS analyst Angus Chan downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR3.10 (from MYR5.90).

The analyst comments: "We downgrade GENT to Neutral, lowering our price target by 47% to reflect our latest price targets for its listed subsidiaries. We expect growth momentum to fade in 2025, on a high base in Malaysia and slow recovery in Las Vegas. This, along with GENM's potential capex in New York, could limit the flow of dividends from GENM to GENT. As a partial offset, the improving outlook in Singapore should provide downside support. GENS' strong balance

UBS Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Sun, 08 Jun 2025 23:59:08 -0500

UBS analyst Angus Chan downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR3.10 (from MYR5.90).

UBS Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Sun, 08 Jun 2025 23:59:08 -0500

UBS analyst Angus Chan downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR3.10 (from MYR5.90).

UBS Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Sun, 08 Jun 2025 23:59:08 -0500

UBS analyst Angus Chan downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR3.10 (from MYR5.90).

UBS Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Sun, 08 Jun 2025 23:59:08 -0500

UBS analyst Angus Chan downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR3.10 (from MYR5.90).

UBS Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Sun, 08 Jun 2025 23:59:08 -0500

UBS analyst Angus Chan downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR3.10 (from MYR5.90).

Nomura/Instinet Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Mon, 02 Jun 2025 05:03:54 -0500

Nomura/Instinet analyst Tushar Mohata downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR2.90 (from MYR5.80).

Nomura/Instinet Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Mon, 02 Jun 2025 05:03:54 -0500

Nomura/Instinet analyst Tushar Mohata downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR2.90 (from MYR5.80).

Nomura/Instinet Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Mon, 02 Jun 2025 05:03:54 -0500

Nomura/Instinet analyst Tushar Mohata downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR2.90 (from MYR5.80).

Nomura/Instinet Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Mon, 02 Jun 2025 05:03:54 -0500

Nomura/Instinet analyst Tushar Mohata downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR2.90 (from MYR5.80).

Nomura/Instinet Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Mon, 02 Jun 2025 05:03:54 -0500

Nomura/Instinet analyst Tushar Mohata downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR2.90 (from MYR5.80).

Nomura/Instinet Downgrades Genting Bhd (GENT:MK) (GEBHY) to Neutral

Mon, 02 Jun 2025 05:03:54 -0500

Nomura/Instinet analyst Tushar Mohata downgraded Genting Bhd (GENT:MK) (OTC: GEBHY) from Buy to Neutral with a price target of MYR2.90 (from MYR5.80).

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

Wed, 28 May 2025 09:00:00 -0500

New technology has potential to accelerate timelines for therapeutic research and drug development

SAN DIEGO--(BUSINESS WIRE)-- Telesis Bio Inc. (OTCMKTS: TBIO), a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced a new license agreement with Regeneron Pharmaceuticals, Inc. to deploy Telesis Bio’s revolutionary Gibson SOLA™ platform at its R&D core facilities. This will help Regeneron adopt automated, high-throughput, on-demand gene synthesis in their own labs.